These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 17672309)

  • 41. Improved immunogenicity of recombinant Mycobacterium bovis bacillus Calmette-Guérin strains expressing fusion protein Ag85A-ESAT-6 of Mycobacterium tuberculosis.
    Deng YH; Sun Z; Yang XL; Bao L
    Scand J Immunol; 2010 Oct; 72(4):332-8. PubMed ID: 20883318
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pulmonary delivery of DNA encoding Mycobacterium tuberculosis latency antigen Rv1733c associated to PLGA-PEI nanoparticles enhances T cell responses in a DNA prime/protein boost vaccination regimen in mice.
    Bivas-Benita M; Lin MY; Bal SM; van Meijgaarden KE; Franken KL; Friggen AH; Junginger HE; Borchard G; Klein MR; Ottenhoff TH
    Vaccine; 2009 Jun; 27(30):4010-7. PubMed ID: 19389445
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunogenicity and therapeutic effects of Ag85A/B chimeric DNA vaccine in mice infected with Mycobacterium tuberculosis.
    Liang Y; Wu X; Zhang J; Xiao L; Yang Y; Bai X; Yu Q; Li Z; Bi L; Li N; Wu X
    FEMS Immunol Med Microbiol; 2012 Dec; 66(3):419-26. PubMed ID: 23163873
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A combined DNA vaccine enhances protective immunity against Mycobacterium tuberculosis and Brucella abortus in the presence of an IL-12 expression vector.
    Yu DH; Li M; Hu XD; Cai H
    Vaccine; 2007 Sep; 25(37-38):6744-54. PubMed ID: 17681650
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Protective efficacy of DNA vaccines encoding mycobacterium tuberculosis Ag85B protein].
    Fan XL; Xu ZK; Li Y; Li BH; Xue Y; Bai YL; Bai GC; Jia XZ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Jan; 19(1):90-2. PubMed ID: 15132919
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Investigation of immunogenic effect of the BCG priming and Ag85A- GM-CSF boosting in Balb/c mice model.
    Dou J; Tang Q; Yu F; Yang H; Zhao F; Xu W; Wang J; Hu W; Hu K; Liou C; Feng He X; Wang Y
    Immunobiology; 2010; 215(2):133-42. PubMed ID: 19450898
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Therapeutic effects of Ag85B and MPT64 DNA vaccines in a murine model of Mycobacterium tuberculosis infection.
    Zhu D; Jiang S; Luo X
    Vaccine; 2005 Aug; 23(37):4619-24. PubMed ID: 16053938
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Prokaryotic expression and immunological characteristics of Mycobacterium tuberculosis Rv1886c].
    Tao C; Zhao D; Dong H; Shan F; Lian K; Pan Z; Chen X; Yin Y; Jiao X
    Wei Sheng Wu Xue Bao; 2014 Mar; 54(3):330-7. PubMed ID: 24984525
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cloning, expression, and immunogenicity of novel fusion protein of Mycobacterium tuberculosis based on ESAT-6 and truncated C-terminal fragment of HSP70.
    Tebianian M; Hoseini AZ; Ebrahimi SM; Memarnejadian A; Mokarram AR; Mahdavi M; Sohrabi N; Taghizadeh M
    Biologicals; 2011 May; 39(3):143-8. PubMed ID: 21388826
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased IgG1, IFN-gamma, TNF-alpha and IL-6 responses to Mycobacterium tuberculosis antigens in patients with tuberculosis are lower after chemotherapy.
    Mattos AM; Almeida Cde S; Franken KL; Alves CC; Abramo C; de Souza MA; L'Hotellier M; Alves MJ; Ferreira AP; Oliveira SC; Ottenhoff TH; Teixeira HC
    Int Immunol; 2010 Sep; 22(9):775-82. PubMed ID: 20624776
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Immune response and protective efficacy induced by fusion protein ESAT6-CFP10 of M.tuberculosis in mice].
    Zhang H; Shi CH; Xue Y; Bai YL; Wang LM; Xu ZK
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Jul; 22(4):443-6. PubMed ID: 16806004
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An attenuated Salmonella-vectored vaccine elicits protective immunity against Mycobacterium tuberculosis.
    Wang QL; Pan Q; Ma Y; Wang K; Sun P; Liu S; Zhang XL
    Vaccine; 2009 Nov; 27(48):6712-22. PubMed ID: 19733584
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Combined recombinant DNA vaccine results in significant protection against Mycobacterium tuberculosis].
    Pan Y; Cai H; Li SX; Tian X; Li T; Zhu YX
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Jan; 35(1):71-6. PubMed ID: 12518231
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Enhanced protection against tuberculosis by vaccination with recombinant Mycobacterium microti vaccine that induces T cell immunity against region of difference 1 antigens.
    Brodin P; Majlessi L; Brosch R; Smith D; Bancroft G; Clark S; Williams A; Leclerc C; Cole ST
    J Infect Dis; 2004 Jul; 190(1):115-22. PubMed ID: 15195250
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Improved humoral immunity against tuberculosis ESAT-6 antigen by chimeric DNA prime and protein boost strategy.
    Li Z; Song D; Zhang H; He W; Fan X; Zhang Y; Huang J; Wang X; Liu Q; Xiong S
    DNA Cell Biol; 2006 Jan; 25(1):25-30. PubMed ID: 16405398
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mycobacterium tuberculosis ESX-1 system-secreted protein ESAT-6 but not CFP10 inhibits human T-cell immune responses.
    Samten B; Wang X; Barnes PF
    Tuberculosis (Edinb); 2009 Dec; 89 Suppl 1():S74-6. PubMed ID: 20006311
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recombinant M. smegmatis vaccine targeted delivering IL-12/GLS into macrophages can induce specific cellular immunity against M. tuberculosis in BALB/c mice.
    Yi Z; Fu Y; Yang C; Li J; Luo X; Chen Q; Zeng W; Jiang S; Jiang Y; He Y; Yang J; Liu Y; Li N; Zhu DY
    Vaccine; 2007 Jan; 25(4):638-48. PubMed ID: 17000035
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunotherapeutic effects of Mycobacterium tuberculosis rv3407 DNA vaccine in mice.
    Liang Y; Zhao Y; Bai X; Xiao L; Yang Y; Zhang J; Wang L; Cui L; Wang T; Shi Y; Zhao W; Wu X
    Autoimmunity; 2018 Dec; 51(8):417-422. PubMed ID: 30632804
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pseudo-rationale design of efficient TB vaccines: lesson from the mycobacterial 27-kDa lipoprotein.
    Hovav AH; Bercovier H
    Tuberculosis (Edinb); 2006; 86(3-4):225-35. PubMed ID: 16515885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.